Fourth Quarter and Near-Term EBITDA
Fourth-quarter operating EBITDA of $741 million; first-quarter 2026 EBITDA guidance ~ $750 million, representing a modest sequential improvement driven by expected margin expansion and seasonal uplift.
Substantial Cost Savings Delivered
Identified more than $6.5 billion in near-term cash support items and delivered well over half in 2025; accelerated delivery of $1.0 billion cost-out program (realized > $400 million vs original $300 million target) and expect to deliver the remaining > $500 million by end of 2026.
Transform to Outperform Program
New transformation expected to deliver at least $2.0 billion in near-term EBITDA improvement (≈66% from productivity, ≈33% from growth); company expects ~ $500 million of value in 2026 from this initiative while incurring estimated one-time costs of $1.1–$1.5 billion (including $600–$800 million severance).
Strong Liquidity and Balance Sheet Actions
Cash and cash equivalents > $3.8 billion at end of 2025 and approximately $14 billion of available liquidity (including renewed revolver to 2030); completed ~$3.0 billion cash proceeds from strategic partnership with Macquarie and $2.4 billion in bond issuances; reduced CapEx plans by $1.0 billion.
Packaging & Specialty Plastics Operational Strength
Q4 net sales $4.7 billion; polyethylene sales volume increased year-over-year and sequentially; operating EBIT $215 million and sequentially improved by $16 million due to cost savings, higher licensing and energy sales; annual ethylene production record set for third consecutive year and startup of Poly 7 polyethylene train completed.
Performance Materials & Coatings Profitability Upside
Q4 net sales $1.9 billion (down 6% YoY) but operating EBIT increased by $34 million YoY driven by strong demand in electronics and mobility and cost reduction; silicones downstream volumes increased for the second consecutive year.
Industry Rationalization and Strategic Asset Actions
Completed shutdowns of higher-cost upstream assets (including shuttering a Freeport propylene oxide unit that rationalized ~20% of North American PO capacity); announced European shutdowns expected to deliver ~$200 million annual EBITDA uplift by 2029 with benefits starting in 2026.
Path to Zero Strategic Rework
Path to Zero timeline delayed two years to late 2029 to align with recovery; ~30% of project CapEx complete; expected project returns now ~8–10% with potential upside of 100–200 bps from low-carbon premiums; CapEx spending planned at or below D&A until mid-cycle earnings.